Ligand Pharmaceuticals News

Benchmark: Reiterates Ligand Pharmaceuticals (LGND.US) rating, adjusted from buy to buy rating, target price of $95.00.

Zhitong FinanceApr 12 21:20

Ligand Pharmaceuticals Analyst Ratings

BenzingaApr 12 21:12

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

BenzingaApr 12 21:14

Ligand Pharmaceuticals Analyst Ratings

BenzingaMar 1 04:38

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

BenzingaDec 13, 2023 23:47

Ligand Pharmaceuticals Analyst Ratings

BenzingaDec 13, 2023 23:46

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

BenzingaSep 20, 2023 00:01

Ligand Pharmaceuticals Analyst Ratings

BenzingaSep 20, 2023 00:00

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

BenzingaAug 23, 2023 22:02

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 23, 2023 22:00

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

BenzingaAug 9, 2023 18:37

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 9, 2023 18:37

Barclays Cuts Price Target on Ligand Pharmaceuticals to $110 From $120, Maintains Overweight Rating

MT NewswiresJul 25, 2023 21:47

Barclays Maintains Overweight on Ligand Pharmaceuticals, Lowers Price Target to $110

BenzingaJul 25, 2023 18:59

Ligand Pharmaceuticals Analyst Ratings

BenzingaJul 25, 2023 18:57

Ligand Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsFeb 21, 2023 22:00

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

Benzinga Real-time NewsFeb 21, 2023 21:45

Tesla To $175? Here Are 10 Other Price Target Changes For Friday

Benzinga Real-time NewsDec 23, 2022 22:26

Ligand Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsDec 23, 2022 20:46

Roth Capital Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $90

Benzinga Real-time NewsDec 23, 2022 20:46